Dai Chihara, MD
Researcher Spotlight: Dai Chihara, MD UNIVERSITY OF TEXAS M.D. ANDERSON CANCER CENTER Phase I trials are the first step in transitioning new drugs from the bench to the clinic. These trials are intended to evaluate the safety and tolerability of…